Jingyi Yang

Jinan, 250014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

The histone-modified landscape: Core mechanisms of osimertinib resistance in EGFR-mutant lung cancer.

The histone-modified landscape: Core mechanisms of osimertinib resistance in EGFR-mutant lung cancer.

Journal: Cancer letters

Published: November 26, 2025

Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions.

Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions.

Journal: Molecular biomedicine

Published: August 12, 2025

Liver organoids and their application in liver cancer research.

Liver organoids and their application in liver cancer research.

Journal: Regenerative therapy

Published: October 18, 2023

Hyperuricemia research progress in model construction and traditional Chinese medicine interventions.

Hyperuricemia research progress in model construction and traditional Chinese medicine interventions.

Journal: Frontiers in pharmacology

Published: September 22, 2023

Material basis revelation of anti-hepatoma effect of Huachansu (Cinobufacini) through down-regulation of thymidylate synthase.

Material basis revelation of anti-hepatoma effect of Huachansu (Cinobufacini) through down-regulation of thymidylate synthase.

Journal: Chinese herbal medicines

Published: May 06, 2023

Dual-Mechanism Glycolipidpeptide with High Antimicrobial Activity, Immunomodulatory Activity, and Potential Application for Combined Antibacterial Therapy.

Dual-Mechanism Glycolipidpeptide with High Antimicrobial Activity, Immunomodulatory Activity, and Potential Application for Combined Antibacterial Therapy.

Journal: ACS nano

Published: March 23, 2023

Integrated transcriptomics and metabolomics analyses to investigate the anticancer mechanisms of cinobufagin against liver cancer through interfering with lipid, amino acid, carbohydrate, and nucleotide metabolism.

Integrated transcriptomics and metabolomics analyses to investigate the anticancer mechanisms of cinobufagin against liver cancer through interfering with lipid, amino acid, carbohydrate, and nucleotide metabolism.

Journal: Bioorganic chemistry

Published: July 02, 2022

Cinobufagin restrains the growth and triggers DNA damage of human hepatocellular carcinoma cells via proteasome-dependent degradation of thymidylate synthase.

Cinobufagin restrains the growth and triggers DNA damage of human hepatocellular carcinoma cells via proteasome-dependent degradation of thymidylate synthase.

Journal: Chemico-biological interactions

Published: December 21, 2021

The traditional Chinese medicine Achyranthes bidentata and our de novo conception of its metastatic chemoprevention: from phytochemistry to pharmacology.

The traditional Chinese medicine Achyranthes bidentata and our de novo conception of its metastatic chemoprevention: from phytochemistry to pharmacology.

Journal: Scientific reports

Published: October 24, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026